These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25778534)

  • 1. Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling.
    Jitschin R; Braun M; Qorraj M; Saul D; Le Blanc K; Zenz T; Mougiakakos D
    Blood; 2015 May; 125(22):3432-6. PubMed ID: 25778534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lymphocytic leukemia and the Warburg effect.
    Moreno C
    Blood; 2015 May; 125(22):3368-9. PubMed ID: 26022050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis.
    Böttcher M; Bruns H; Völkl S; Lu J; Chartomatsidou E; Papakonstantinou N; Mentz K; Büttner-Herold M; Zenz T; Herling M; Huber W; Ghia P; Stamatopoulos K; Mackensen A; Mougiakakos D
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells.
    Vangapandu HV; Ayres ML; Bristow CA; Wierda WG; Keating MJ; Balakrishnan K; Stellrecht CM; Gandhi V
    Neoplasia; 2017 Oct; 19(10):762-771. PubMed ID: 28863345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of
    Biran A; Yin S; Kretzmer H; Ten Hacken E; Parvin S; Lucas F; Uduman M; Gutierrez C; Dangle N; Billington L; Regis FF; Rassenti LZ; Mohammad A; Hoffmann GB; Stevenson K; Zheng M; Witten E; Fernandes SM; Tausch E; Sun C; Stilgenbauer S; Brown JR; Kipps TJ; Aster JC; Gnirke A; Neuberg DS; Letai A; Wang L; Carrasco RD; Meissner A; Wu CJ
    Cancer Res; 2021 Dec; 81(24):6117-6130. PubMed ID: 34686499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
    Ghosh AK; Secreto CR; Knox TR; Ding W; Mukhopadhyay D; Kay NE
    Blood; 2010 Mar; 115(9):1755-64. PubMed ID: 20018914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia.
    von Heydebrand F; Fuchs M; Kunz M; Voelkl S; Kremer AN; Oostendorp RAJ; Wilke J; Leitges M; Egle A; Mackensen A; Lutzny-Geier G
    Stem Cells; 2021 Jun; 39(6):819-830. PubMed ID: 33539629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
    Crompot E; Van Damme M; Pieters K; Vermeersch M; Perez-Morga D; Mineur P; Maerevoet M; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
    Haematologica; 2017 Sep; 102(9):1594-1604. PubMed ID: 28596280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53-induced glycolysis and apoptosis regulator protects from spontaneous apoptosis and predicts poor prognosis in chronic lymphocytic leukemia.
    Hong M; Xia Y; Zhu Y; Zhao HH; Zhu H; Xie Y; Fan L; Wang L; Miao KR; Yu H; Miao YQ; Wu W; Zhu HY; Chen YY; Xu W; Qian SX; Li JY
    Leuk Res; 2016 Nov; 50():72-77. PubMed ID: 27693855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.
    Balakrishnan K; Burger JA; Fu M; Doifode T; Wierda WG; Gandhi V
    Neoplasia; 2014 Dec; 16(12):1036-46. PubMed ID: 25499217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?
    Galicia-Vázquez G; Aloyz R
    Crit Rev Oncol Hematol; 2019 Feb; 134():65-70. PubMed ID: 30771875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.
    Kurtova AV; Balakrishnan K; Chen R; Ding W; Schnabl S; Quiroga MP; Sivina M; Wierda WG; Estrov Z; Keating MJ; Shehata M; Jäger U; Gandhi V; Kay NE; Plunkett W; Burger JA
    Blood; 2009 Nov; 114(20):4441-50. PubMed ID: 19762485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Notch signal pathway and chronic lymphocytic leukemia].
    Zhang JY; Xu ZS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1472-5. PubMed ID: 25338610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia.
    Zhang W; Trachootham D; Liu J; Chen G; Pelicano H; Garcia-Prieto C; Lu W; Burger JA; Croce CM; Plunkett W; Keating MJ; Huang P
    Nat Cell Biol; 2012 Feb; 14(3):276-86. PubMed ID: 22344033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways?
    Seke Etet PF; Vecchio L; Nwabo Kamdje AH
    Cell Signal; 2012 Jul; 24(7):1433-43. PubMed ID: 22446006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.
    Rosati E; Sabatini R; De Falco F; Del Papa B; Falzetti F; Di Ianni M; Cavalli L; Fettucciari K; Bartoli A; Screpanti I; Marconi P
    Int J Cancer; 2013 Apr; 132(8):1940-53. PubMed ID: 23001755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
    Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
    Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
    Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
    Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.